Previous studies have reported that IGF-1 levels are reduced in schizophrenia (17), and that the reduced IGF-1 levels may be involved in the pathogenesis, particularly in the negative symptoms, of schizophrenia (18). Here, IGF1 is linked to schizophrenia.